Rating History for Sage Therapeutics (SAGE) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for SAGE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/17/2025 David Amsellem Downgrade Neutral
(Overweight)		 8.50
(9.00)		 6.70
(8.68)		 29.55% Details